Literature DB >> 9157158

Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones.

T Deguchi1, M Yasuda, M Nakano, E Kanematsu, S Ozeki, Y Nishino, T Ezaki, S Maeda, I Saito, Y Kawada.   

Abstract

To detect quinolone resistance-associated mutations within the Asp-86, Ser-87, Ser-88, and Glu-91 codons of the Neisseria gonorrhoeae parC gene, we developed a rapid and simple assay based on amplification of the regions of the parC gene containing the mutations sites by PCR and digestion of the PCR products with restriction enzymes. By using the method of primer-specified restriction site modification, artificial SalI, PstI, EcoRI, and HinfI restriction sites were created in the regions containing the Asp-86, Ser-87, Ser-88, and Glu-91 codons, respectively. The mutations generating alterations at Asp-86, Ser-87, Ser-88, and Glu-91 were detected as failures of SalI, PstI, EcoRI, and HinfI to digest the respective PCR products. Fifty-five clinical strains of N. gonorrhoeae were examined for mutations in the parC gene by this assay. Appropriate mutations at either the Asp-86, Ser-87, Ser-88, or Glu-91 codon were detected in each of 11 strains in which a mutation had previously been observed by DNA sequencing. This rapid and simple assay could be a useful device for screening genetic alterations in the parC gene associated with resistance to quinolones in N. gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157158      PMCID: PMC229706          DOI: 10.1128/jcm.35.4.948-950.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Failure of 500 mg ciprofloxacin therapy in male urethral gonorrhoea.

Authors:  J W Tapsall; T R Shultz; R Lovett; R Munro
Journal:  Med J Aust       Date:  1992-01-20       Impact factor: 7.738

2.  Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains.

Authors:  J E Corkill; A Percival; M Lind
Journal:  J Antimicrob Chemother       Date:  1991-10       Impact factor: 5.790

Review 3.  Fluoroquinolone antimicrobial agents.

Authors:  D C Hooper; J S Wolfson
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

4.  Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  W R Gransden; C A Warren; I Phillips; M Hodges; D Barlow
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

5.  Modification of enzymatically amplified DNA for the detection of point mutations.

Authors:  A Haliassos; J C Chomel; L Tesson; M Baudis; J Kruh; J C Kaplan; A Kitzis
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

6.  High level ciprofloxacin resistance in Neisseria gonorrhoeae.

Authors:  H Birley; P McDonald; P Carey; J Fletcher
Journal:  Genitourin Med       Date:  1994-08

7.  High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.

Authors:  M Tanaka; J Kumazawa; T Matsumoto; I Kobayashi
Journal:  Genitourin Med       Date:  1994-04

8.  Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae.

Authors:  D C Stein; R J Danaher; T M Cook
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

9.  Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.

Authors:  R J Belland; S G Morrison; C Ison; W M Huang
Journal:  Mol Microbiol       Date:  1994-10       Impact factor: 3.501

10.  Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan.

Authors:  M Tanaka; H Fukuda; K Hirai; M Hosaka; T Matsumoto; J Kumazawa
Journal:  Genitourin Med       Date:  1994-08
View more
  6 in total

1.  Use of applied biosystems 7900HT sequence detection system and Taqman assay for detection of quinolone-resistant Neisseria gonorrhoeae.

Authors:  Julie Giles; Justin Hardick; Jeffrey Yuenger; Michael Dan; Karl Reich; Jonathan Zenilman
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae.

Authors:  D L Trees; A L Sandul; W L Whittington; J S Knapp
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 3.  Mechanisms of fluoroquinolone resistance: an update 1994-1998.

Authors:  L J Piddock
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis.

Authors:  C M Bebear; J Renaudin; A Charron; H Renaudin; B de Barbeyrac; T Schaeverbeke; C Bebear
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

5.  The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds.

Authors:  Corinne Rouquette-Loughlin; Steven A Dunham; Michael Kuhn; Jacqueline T Balthazar; William M Shafer
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

6.  Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure.

Authors:  C A Ison; P J Woodford; H Madders; E Claydon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.